BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19752554)

  • 21. Successful management with CHOP for pulmonary lymphomatoid granulomatosis in a dog.
    Hatoya S; Kumagai D; Takeda S; Yamamoto E; Nakanishi M; Kuwamura M; Sugiura K; Sasai H; Yamate J; Inaba T
    J Vet Med Sci; 2011 Apr; 73(4):527-30. PubMed ID: 21139353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b.
    Wilson WH; Kingma DW; Raffeld M; Wittes RE; Jaffe ES
    Blood; 1996 Jun; 87(11):4531-7. PubMed ID: 8639820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lymphomatoid granulomatosis revealed by cutaneous lesions].
    Quéreux G; Brocard A; Peuvrel L; Knol AC; Renaut JJ; Dréno B
    Ann Dermatol Venereol; 2011; 138(8-9):591-6. PubMed ID: 21893233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal haemoptysis in a case of lymphomatoid granulomatosis treated with rituximab.
    Jaffre S; Jardin F; Dominique S; Duet E; Hubscher P; Genevois A; Corne F; Bota S; Nouvet G; Thiberville L
    Eur Respir J; 2006 Mar; 27(3):644-6. PubMed ID: 16507866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphomatoid granulomatosis in a 23-year-old man--cytological and histological typing and rapid response to steroid and cyclophosphamide combination therapy.
    Rakusić N; Krmpotić D; Hećimović A; Boras Z; Vrabec-Branica B; Dzebro S; Rakusić N; Resković T; Rakusić N
    Coll Antropol; 2010 Mar; 34(1):279-83. PubMed ID: 20437644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term remission after multiple relapses in an elderly patient with lymphomatoid granulomatosis after rituximab and high-dose cytarabine chemotherapy without stem-cell transplantation.
    Aoki T; Harada Y; Matsubara E; Morishita T; Suzuki T; Kasai M; Uchida T; Tsuzuki T; Nakamura S; Ogura M
    J Clin Oncol; 2013 Aug; 31(22):e390-3. PubMed ID: 23796993
    [No Abstract]   [Full Text] [Related]  

  • 27. Lymphomatoid granulomatosis. A case for aggressive therapy.
    Jenkins TR; Zaloznik AJ
    Cancer; 1989 Sep; 64(6):1362-5. PubMed ID: 2475241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lymphomatoid granulomatosis--a short description of an unusual case of the disease].
    Bräunlich J; Seyfarth HJ; Gessner C; Gradistanac T; Wirtz H
    Pneumologie; 2009 Dec; 63(12):697-701. PubMed ID: 19890779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rituximab in lymphomatoid granulomatosis.
    Hernández-Marqués C; Lassaletta A; Torrelo A; López-Pino MÁ; Álvarez-Coca J; De Prada I; Hernández-Martín Á; Madero L
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):e69-74. PubMed ID: 23337550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy.
    Sebire NJ; Haselden S; Malone M; Davies EG; Ramsay AD
    J Clin Pathol; 2003 Jul; 56(7):555-7. PubMed ID: 12835306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary lymphomatoid granulomatosis presenting with neuropathy and renal nodules.
    Pathak V; Aryal G; Clouse LH
    WMJ; 2012 Apr; 111(2):61-4; quiz 65. PubMed ID: 22616473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary Orbital Lymphomatoid Granulomatosis in a 1-Year-Old Child.
    Aboobaker S; Tinley C
    Middle East Afr J Ophthalmol; 2015; 22(4):517-9. PubMed ID: 26692728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relapsed pulmonary lymphomatoid granulomatosis grade III: curative treatment with radioimmune therapy and autologous stem cell transplantation].
    Friedrichs B; Thiel E
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1857-60. PubMed ID: 20842604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
    Trappe R; Oertel S; Leblond V; Mollee P; Sender M; Reinke P; Neuhaus R; Lehmkuhl H; Horst HA; Salles G; Morschhauser F; Jaccard A; Lamy T; Leithäuser M; Zimmermann H; Anagnostopoulos I; Raphael M; Riess H; Choquet S; ;
    Lancet Oncol; 2012 Feb; 13(2):196-206. PubMed ID: 22173060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphomatoid Granulomatosis: A Single Institution Experience and Review of the Literature.
    Chavez JC; Sandoval-Sus J; Horna P; Dalia S; Bello C; Chevernick P; Sotomayor EM; Sokol L; Shah B
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S170-4. PubMed ID: 27521314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphomatoid granulomatosis with long survival.
    Al-Arfaj AS
    Saudi Med J; 2001 Jun; 22(6):541-3. PubMed ID: 11426249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolated lymphomatoid granulomatosis of the central nervous system: A case report and literature review.
    He C; Wang Y; Zhang L; Lu C; Ge W; Zhang Q; Gui Q; Liu R; Yu S
    Neuropathology; 2019 Dec; 39(6):479-488. PubMed ID: 31746046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute respiratory failure developing in a patient with lymphomatoid granulomatosis.
    Nomura M; Yuzawa M; Hiruta M; Ohta H
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38103907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatal lymphomatoid granulomatosis with primary CNS-involvement in an immunocompetent 80-year-old woman.
    Olmes DG; Agaimy A; Kloska S; Linker RA
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25535225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Spontaneous Regression of Grade 3 Methotrexate-related Lymphomatoid Granulomatosis: A Case Report and Literature Review.
    Aiko N; Sekine A; Umeda S; Katano T; Matama G; Isomoto K; Otoshi R; Ogura T
    Intern Med; 2018 Nov; 57(21):3163-3167. PubMed ID: 29877270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.